Haemonetics - M&A Summary and Business Overview

Medical ProductsCompany

Haemonetics M&A Summary

Haemonetics has acquired 15 companies, including 4 in the last 5 years. A total of 1 acquisition came from private equity firms. It has also divested 3 assets.

Haemonetics’ largest acquisition to date was in 2012, when it acquired Pall - Transfusion Medicine Business for $551M. Haemonetics has acquired in 7 different US states, and 3 countries. The Company’s most targeted sectors include medical products (54%) and software (27%).

Haemonetics Business Overview

Where is Haemonetics headquartered?

Haemonetics is headquartered in Boston, Massachusetts.

What is Haemonetics’ revenue?

Haemonetics disclosed revenue of 1,309M USD for 2024 and 1,169M USD for 2023.

How many employees does Haemonetics have?

Haemonetics has 2,708 employees.

What sector is Haemonetics in?

Haemonetics is a medical products company.

When was Haemonetics founded?

Haemonetics was founded in 1971.

M&A Summary

  • M&A Total Activity18
    • M&A Buy Activity15
    • M&A Sell Activity3
  • Total Sectors Invested 4
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 5
  • M&A Advisors 3

Haemonetics

Haemonetics Corp.

125 Summer Street,
Boston, Massachusetts 02110
United States,
(781) 848-7100
www.haemonetics.com

Haemonetics is a healthcare company dedicated to providing innovative blood management solutions for customers. The company devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients worldwide. Haemonetics was founded in 1971 and is based in Boston, Massachusetts.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.6/yr) # 12 1 - 1 1 - 15
vol $731M $475M $253M $1.5B
Sell (0.2/yr) # 2 - - - - 1 3
  18

Most Recent M&A

Company Date Value Type
Haemonetics - Blood Center business 2025-01-15 - Divestiture
Boston, Massachusetts
Advanced Cooling Therapy, Inc. 2024-03-05 - Add-on Acquisition
Chicago, Illinois · www.attune-medical.com
OpSens, Inc. 2023-10-10 253M USD Add-on Acquisition
Quebec City, Quebec · www.opsens.com
Cardiva Medical, Inc. 2021-01-20 475M USD Add-on Acquisition
Sunnyvale, California · www.cardivamedical.com
Inlog Holdings France SAS 2020-07-24 - Divestiture
Limonest, France
enicor GmbH 2020-04-02 - Add-on Acquisition
Munich, Germany · www.clot.pro
Haemonetics Corp. - SEBRA 2017-04-27 - Divestiture
Braintree, Massachusetts
Hemerus Medical LLC 2013-05-01 27M USD Add-on Acquisition
St. Paul, Minnesota · www.hemerus.com
Pall - Transfusion Medicine Business 2012-08-01 551M USD Divestiture
, United States
Global Med Technologies, Inc. 2010-02-01 60M USD Add-on Acquisition
El Dorado Hills, California · www.globalmedtech.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Medical Products 8 (53%) 1.4B (93%) 2 (67%) -
Software 4 (27%) 70M (5%) 1 (33%) -
Life Science 2 (13%) 13M (1%) - -
Test/Measurement Equipment 1 (7%) 26M (2%) - -
Total 15 $1.5B 3 -

By Geo

State/Country Buy Value Sell Value
United States 12 1.2B 2 -
  Illinois 4 79M - -
  California 3 535M - -
  Massachusetts 1 - 2 -
  Pennsylvania 1 1M - -
  Minnesota 1 27M - -
  Arizona 1 13M - -
Canada 2 253M - -
  Quebec 1 253M - -
  British Columbia 1 - - -
France - - 1 -
Germany 1 - - -
Domestic 12 (80%) 1.2B (83%) 2 (67%) -
Cross-border 3 (20%) 253M (17%) 1 (33%) -
Total 15 $1.5B 3 -

Top M&A Advisors

Financial Deals
Goldman Sachs
1
Moelis & Co.
1
Legal Deals
DLA Piper
3

Deal Values

buy # Total
$100M to $1B 3 $1.3B
< $100M 7 $180M
TOTAL $1.5B
Largest Pall - Transfusion Medicine Business
$551M (2012-08-01)

M&A Connections

Deals
Acquired from
Investor(s)
7%
1 (7%)
Strategic(s)
7%
1 (7%)
Divested to
Investor(s)
33%
1 (33%)
Strategic(s)
67%
2 (67%)

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Haemonetics

Medical Products Companies